Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Completed

Phase 3 Results

Eligibility Criteria

Inclusion Criteria

- 20 years or older
- Japanese male or female
- Non- valvular atrial fibrillation documented by ECG
- Patients with a risk of stroke and non-CNS systemic embolism

Exclusion Criteria

- Significant mitral stenosis
- Patients in whom anticoagulants are contraindicated